A new bill introduced in the U.S. House of Representatives would prevent the FDA from loosening important safety restrictions (known as REMS) for the abortion pill (mifepristone). According to a press release from the office of Rep. Robert E. Latta (R-OH), the Support and Value Expectant (SAVE) Moms & Babies Act, legislation addresses “many of the concerns surrounding … Continue reading ‘SAVE Moms & Babies Act’ introduced in House to keep FDA abortion pill safeguards in place